Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-06 4:15 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Soleus Private Equity Fund III L.P. | 48,887,095 7% | 500,000 (+1.03%) | View |
| 2024-02-06 4:15 pm Sale | 13G | HARPOON THERAPEUTICS INC HARP | Soleus Private Equity Fund III L.P. | 1,820,365 9.99% | -47,690 (-2.55%) | View |
| 2024-01-10 09:00 am Purchase | 13G | IMMUNIC INC IMUX | Soleus Private Equity Fund III L.P. | 7,293,007 8.1% | 7,293,007 (New Position) | View |
| 2023-10-26 5:00 pm Purchase | 13G | HARPOON THERAPEUTICS INC HARP | Soleus Private Equity Fund III L.P. | 1,868,055 9.99% | 1,868,055 (New Position) | View |
| 2023-07-26 4:31 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Soleus Private Equity Fund III L.P. | 48,387,095 7.5% | 48,387,095 (New Position) | View |
| 2023-05-24 4:31 pm Purchase | 13G | INSPIREMD INC NSPR | Soleus Private Equity Fund III L.P. | 2,199,118 9.9% | 2,199,118 (New Position) | View |